Exam 1 Flashcards

1
Q

What is a virus?

A

It is a small collection of genetic code (DNA or RNA), surrounded by a protein coat.

  • Need a host to replicate
  • Often cause damage to host cells in the process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

History of Virology

Small Pox

A

Lady Mary Wortley Montagu and Edward Jenner

  • 16th century disease killed an estimated 400k Europeans
  • Jenner and Mary scabs are collected from patients inoculated with cowpox (less virulent) and used to inoculate other patients to prevent small pox.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Louis Pasteur

Robert Koch

A
  • French
  • Father of science of microbiology
  • Studied, made beer, wine, and cheese
  • Rabies vaccine development

Robert Koch and Pasteur

  • Jointly proposed the ‘germ theory’
  • Kosh’s postulates (framework for investigating disease)
  • The agent must be present in every case of the disease
  • The agent must be isolated from the host and grown in vitro
  • The disease must be reproduced when the pure cultivated agent is introduced into a healthy susceptible host
  • The same agent must once again be recoverable from newly infected host
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

F.A.J. Loeffler and P. Frosh working in 1898 with Robert Koch

A
  • Foot-and-mouth disease

- First virus of vertebrates discovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Thomas Weller and Ferderick Robbins

A

-The tissue-culture technique

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rosalind Elise Franklin, James Watson, Francis Crick

A
  • Model of DNA

- Structure of DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other historical figures

A
  • Shope: discovered swine influenza
  • Salk and Sabin: developed polio vaccines in the 1950’s
  • Johnson in 1965 discovered the parvovirus of cats
  • Small pox declared eradicated in 1980
  • Montagnier and colleagues discovered HIV in 1984
  • Pederson with colleagues in 1987 discovered FIV
  • Rinderpest declared eradicated globally in 2011
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the three Ds?

A
  • Death
  • Discharge
  • Diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Future: Always a threat of existing foreign animal disease (FAD) or new emerging viruses

A

-United Sates Department of Agriculture Animal and Plant Health Inspection Service

  • July 2021: APHIS study white-tail-deer samples for SARS-Cov-2 for antibodies. Some are exposed, IL, NY, PA
  • November 2021 APHIS Malaysia and African Horse Sickness (AHS)
  • January 2022 APHIS confirmed highly pathogenic Eurasian H5 avian influenza (HPAI) in a wild American wigeon, SC.
  • February 2022: HPAI in a commercial turkey flock, IN.
  • February 2022: expansion of wild bird surveillance for avian influenza

-June 2021: New effort called Flock Defender.

**up to 75% of emerging infectious diseases in humans can also impact the health of animals

**Understanding of viruses, their epidemiology and their control/prevention has been revolutionized by molecular studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chicago area in 2015 and Canine Influenza

A
  • High fever 103F
  • Lethargy
  • Cough
  • Runny nose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Virology

A
  • Preventative medicine (vaccines)
  • Treatment is generally palliative (no anti-viral drugs)
  • Strategy is to control through vaccination and biosecurity
  • Rapid and reliable diagnosis is critical
  • Know they industry you are serving
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Classification and Replication of Viruses

A
  • Can only replicate in living cells of animals plants and bacteria
  • They are obligate parasites
  • Metabolically inert when they are outside the host
  • Rely on metabolic process of host to replicate
  • Some have affinity to particular cell types
  • Cannot capture and store free energy
  • Efficient and economic
  • Origin is uncertain, no fossil forms found
  • Have a genome ability to adapt

Properties of viruses

  • Heat sensitivity: denaturation, enveloped viruses more susceptible
  • pH sensitivity: extremes are destructive
  • Lipid solvents
  • Chemicals: react with amino acids of proteins, some inactivate DNA or RNA
  • Radiation and Ultraviolet light
  • Humidity: different viruses respond differently
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Virus structure and taxonomy

A
  • Capsid (made of capsomeres glycoproteins) and envelop (some)
  • Genome: DNA or RNA
  • Viral proteins are lock and key to host cell receptors, initiating infection
  • Both capsid and the envelop are antigenic

Taxonomy

Based upon

  • Morphology of virion, capsid, and envelope
  • Genome: DNA, RNA, ss, ds, etc
  • Serological relationship (serotypes)
  • Replication strategy
Class I: dsDNA
ClassII: ssDNA
Class III: dsRNA
Class IV: +ssRNA
Class V: -ssRNA
Class VI: ssRNA-RT
Class VII: dsDNA-RT

Retroviruses: ability to synthesize DNA from RNA with a unique enzyme
RNA viruses can have a segmented genome.

  • Herpesviridae dsDNA = creeping
  • Coronaviridae, ssRNA+, Corona = crown
  • Picorna = small rna
  • Retroviridae, ssRNA-RT Retro = backwards
  • Rhabdoviridae, ssRNA -, bullet shape
  • Parvoviridae, ssDNA

Symmetry

  • Isometric (Icosahedral): 20 equilateral triangular faces. Ex: herpes viruses
  • Helical: tubular construction with subunits arranged around the nucleic acid in a coil. Ex: rabies

No symmetry

  • Complex: smallpox virus
  • Filamentous: ebola virus (long snake-shaped)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Viral structure, DIVA principle

A

-Nucleic acid core
-Capsid: protein, protects genome. DETECTION of host’s cell receptor and binding
-Outer envelope
-Physical damage
-Chemical damage: UV radiation leads to chemical modification
-Enzymatic damage: nucleases released by host
*Herpesvirus: fragile
*Parvovirus: persistent in environment
-Viral capsid: capsomeres crystalized for receptor binding studying
Structural: important for viral stability
Non-structural: enzymes involve in viral replication
*Antibodies are generally formed against structural proteins

DIVA PRINCIPLE

*Antibodies formed against non-structural proteins helps differentiate animals vaccinated with inactivated vaccines from naturally infected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Promiscuous and Plastic

A

Promiscuous: having or characterized by many transient sexual relationships.
*Capable of infecting several species

Plastic: exhibiting adaptability to change or variety in the environment (influenza virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SARS-Cov-2

A
  • ACE 2: Angiotensin Converting Enzyme 2, thought to be essential Negative Regulator of the renin-angiotensin system (RAS) essential for cardiac function and blood pressure control. ACE2R is situated in many organs of the body (lungs, brain, endothelium, heart, enterocytes etc)
  • Spike protein (s): mediates the virus entry into host cell and binds to ACE 2 receptor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Groups, serotypes, strains, and isolates

A
  • Strain: is a well characterized virus
  • Virulence: the ability to cause damage to the host specific to each strain
  • Isolate: refers to the virus recovered from a specific host or location
  • Serotype: generally means that immunity is not conferred by previous exposure to a different type (Foot-and-mouth disease). (Sero) types 1-26. Group specific antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Taxonomy basic rules

A
  • Order (virales)
  • Family (viridae)
  • Subfamily (virinae)
  • Genera (virus)
  • Common names (no italics)

Important to recognize where the disease of interest is classified, family and genus, allows prediction of viral characteristics, similarly of disease, transmission and diagnosis.
Ex: measles and canine distemper same genus, clue of how to control it

Grouped by the disease they cause

-Enteric viruses: usually ingestion feco-oral route. Ex:
Picornaviridae, Parvoviridae, Adenoviridae.

-Respiratory viruses: inhalation respiratory transmission
Coronaviridae, Paramyxoviridae, Adenoviridae.

-Arboviruses: arthropod-borne, blood-feeding.
Rhabdoviridae, Flaviviridae, Orbivirus

-Oncogenic viruses: close contact, fomites, sexual contact. Ex:
Papovaviridae, Herpesviridae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Replication of viruses

Cytopathic effects in cell culture

A
  • Knowledge of replication for a particular family of viruses is also helpful to the development of antiviral drugs.
  • Viruses and cells have receptors and an affinity (complementary) that results in attachment
  • Virus are highly specific in attachment sites, but others may have a wide host range.

Cytopathic effects
Cell transformation can occur
1. where cells pile up losing the property of cell inhibition = form giant cells or
2. Form occlusions in the cytoplasm or nucleus
3. Die

Giant cells: syncytia (come together)

  • Herpes virus (Bovine herpes mammillitis),canine distemper virus (Paramyxovirus)
  • New Castle disease- poultry: many cytoplasmic inclusions

**Not all viruses are Cytopathic

Summary of other types of virus cell integration

  • Cytocidal: inhibition of DNA synthesis, cell death. Enteroviruses, reoviruses
  • Persistent, productive: no cytophatic, continue to divide. Rabies, pestiviruses, most retroviruses.
  • Persisten non-productive: Usually nil. Canine distemper virus in brain
  • Transformation: Produce tumors when transplanted to experimental animals. Sarcoma viruses, polyoma virus (genital warts)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Calculating virus infectivity

A

In 1930’s embryonated egg was used
In 1950’s cell cultures have been used
*First influenza vaccine
Still used for isolating viruses

Quantitative Assays of Viruses
-Plaque Assay: dilution that calculates virus concentration.
-Tissue culture infective dose 50
Virus titer of 5x10^6 TCID50/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pathogenesis: the manner of development of a disease

A
  • Exposure without infection
  • Subclinical infection
  • Mild disease
  • Moderate disease
  • Severe disease
  • Death of animal
  • Infection is not synonymous with disease
  • Pathogenicity: is the ability of the virus to cause disease
  • Virulence is a relative measure of pathogenicity (e.g., strain A is more virulent than strain B)
  • Virulence and pathogenicity are unrelated to infectivity and transmissibility

SEROTYPE: generally means the antibodies it produces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Viral Exposure/Infection

A

The outcome depends on

  1. Method of transmission
  2. Number of infecting particles (dose)
  3. Virulence of infecting particles
  4. Speed of viral replication and spread
  5. Degree of cellular damage
  6. Effectiveness of host defenses
  • *Acute clinical disease
  • *Subclinical disease (inapparent infection)
  • *Induction of cancer
  • *Induction of chronic progressive disease, especially of the CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Effects of viruses on the host animal

A
  • Direct damage to cells due to cell death/apoptosis (according to location): paralysis, immune deficiency
  • Disruption of normal cell functions: protein synthesis, secretions, membrane trafficking.
  • Immune response to virus infected cell
  • Immune cell release of cytokines
  • Virus hijacking/expressing host genes

Host factors

  • Outcome of the virus-host encounter is the product of the virulence of the infecting virus and the susceptibility of the host
  • “interplay” between genomes influenced by environment
  1. Genetic: species, breed, organ/tissue
  2. Age: neonate vs. geriatric
  3. Hormonal influence: pregnancy
  4. Healthy living conditions
  5. Concurrent or mixed infections
  6. Exposure to vectors
  7. Immunity (innate/passive): intact membrane barriers, nursing, interferons, phagocytosis. Acquired: previous exposure, vaccination.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Obligatory Steps in viral infections

A
  1. Entry into host and primary viral replication
  2. Local or general spread, cell and tissue tropism, and secondary viral replication
  3. Evasion of host inflammatory and immune responses
  4. Shedding from host
  5. Cause damage to host
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Tropism

A

Certain viruses have evolved to preferentially target certain hosts, tissues or cell types. Examples:

  • Rabies virus: neurotropic
  • Malignant catarrhal fever: vascular system
  • Bovine virus diarrhea: lymphoid tissue

Cellular tropism: HIV and macrophages
Tissue tropism: influenza virus and lung tissue
Host tropism: Myxoma virus only infect rabbits and not humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Rabies Neurotropic, toward CNS

A
  • Direct inoculation
  • Replicates at primary site
  • Tropism-spread to secondary site where its choice cell target cell is CNS
  • Systematic disease occurs
  • Shed in secretions
  • *If restricted to local, then no neurotropic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Herpesvirus moves away from CNS

A
  • Direct inoculation
  • Replicate at primary site
  • Tropism-spread to secondary site, preferred cell.
  • Systematic disease usually occurs
  • Shed in secretions
  • Epithelium, nerves dormant.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Enteric virus-Gastrointestinal tract, Intestinal Epithelium

A
  • Parvo prefers crypt cells (stem cells) where active mitosis is going on. These cells move to the top to become goblet, enterocytes, etc.
  • Rotavirus/Coronavirus: prefers villus, non-replicating cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Respiratory Tract-viruses

A
  • Picornavirus: likes upper cooler tract (35C)

- Paramyxovirus & Influenza: like lower, warmer tract 38C.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Immune system cell viruses -Retroviruses (RNA viruses)

A
  • FIV: targets T-cells, latent and active stage.
  • HIV:
  • BVDV: Lymphoid system. Transient infection to fetus (75 days), poor doer, recognized as self and no immune response mounted.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Principal types of infection

A

-LOCALIZED: limited to site of viral entry. Example:
Skin warts cause by Papillomaviruses.
Respiratory tract local: orthomyxoviruses cause influlenza, rhinoviruses cause “colds” in humans.
Alimentary tract: entero-, reo-, adeno-, rota-, corona-, and parvoviruses replicate only in GI tract, gastroenteritis.

  • SYSTEMATIC: spreads to various organ systems depending on viral tropism. Ex: Canine Distemper.
  • Paramyxoviruses
  • Rotaviruses
  • Papillomaviruses

Variations on the theme of localized and systematic

  • Inapparent infections
  • Immunopathologic disease: Feline infectious Peritonitis
  • Congenital infections: Feline Panleukopenia
  • Persistent and latent infection: Bovine Rhinotracheitis
  • Slow virus infections occur where the incubation period is prolonged: FIV (feline immunodeficiency virus infection.
  • Oncogenicity (Cancer): Feline Leukemia
  • Herpes stays forever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Variations: Congenital Infections

A
  • Viral infections during pregnancy: infection in utero, during birth, congenital defects, fetal death.
  • Virus is usually transferred to the fetus during the viremic phase of the dam. Can result in persistent infections (BVDV PI calf, smaller brain w/ tumor).
  • Reproductive failure, abortions, and teratogenic defects may result.

Influences:
-The stage of gestation at time of infection, transmission to fetus, ability to cause fetal damage. Examples:
Hog cholera, BVDV, bluetongue, feline panleukopenia, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Variations: Persistent and Latent Infections

A
  • Persistent infections:
  • Following a short incubation period with clinical recovery. Ex: foot-and-mouth disease (FMD).
  • Long incubation period (years), a protracted clinical course, usually results in serious disease. Ex: Caprine Arthritis Encephalitis.

*Latent infection: persistent infection in which the latent virus is activated intermittently. Ex: feline viral rhinotracheitis, Herpesvirus (corticosteroid tx)

34
Q

Variations: Inapparent Infections

A
  • Epidemiologically important: serve as an unrecognized source for spread of viruses (COVID-19)
  • Associated with infection of a reservoir species/host, low infectious dose, infection with viruses of low virulence, host resistance. Ex: Malignant catarrhal fever virus and wildebeest (no symptoms), but cattle susceptible species.
35
Q

Variations: Oncogenic Virus Infections

A
  1. Immune evasion
  2. Virus replication and persistance (immune genes factor turned off).
  3. Aberrant cell growth and invasion
  4. Development and progression

-Retroviridae/Gammaretrovirus: FLV, Feline Sarcoma virus, Murine leukemia and sarcoma viruses, Avian reticuloendotheliosis virus (fowl)

  • DNA tumor viruses
  • Papovavirus (warts)
  • Hepadnavirus
  • Herpesvirus
  • Adenovirus
  • Poxvirus
  • RNA tumor viruses:
  • Retroviruses (oncovirinae)
36
Q

Virus shedding (when are animals infectious?)

A
  • Rotavirus, Influenza virus, Rabies: Acute infection. Disease episode: self-limiting
  • Canine distemper virus: Acute infection, rare late complications. Disease episode, virus not readily demonstrable, later SSPE complication.
  • Herpesvirus: Latent-recurrent infections. Disease episode, virus not readily demonstrable, Zoster, disease episode.
  • Canine hepatitis, FIP virus: Chronic infection, hepatitis B/C. Disease episode, Continuous shedding.
  • FeLV, FIV: Chronic infection, late disease, Disease episode, Continuous shedding, Disease episode.
  • Prion disease: Slow infection, Disease episode.
37
Q

Veterinary Virology Diagnosis

A
  • Diagnosis with minimal delay: allows for effective control of disease
  • Pathognomic: characteristic of that disease only. In this case, diagnostic virology maybe unnecessary.
  • Others: foreign zoonotic suspicion important confirmatory diagnosis. Important economic impact, etc.

Practical applications preventive medicine:

  • Clinical management: wide range of rapid diagnosis.
  • Chemotherapy of viral diseases not a practical proposition. Supportive treatment
  • Measures can be established to prevent spread.
  • Diagnostic virology has made most contribution in disease prevention. Ex: FMD, swine vesicular disease, equine influenza, rabies. Control measures can be implemented promptly. Canine distemper confirmation in boarding kennel, vaccination and segregation enforced.
  • Provides disease surveillance at local, national, international level. Emergence of new viruses identified, animal movement.
38
Q

Where do I start?

A
  1. Clinical examination, possible pathognomonic sigs.
  2. Collection of samples sent to labs likely to help provide a diagnosis
    - Titer (number of viral particles) usually highest at affected site, during early stages of disease.
    - Some diseases have viremia the maximum titer peak of pyrexia
    - Secondary bacterial infection, common sequel of virus disease. Postmortem less likely to contain viable virus
39
Q

Selection of specimens

A

Respiratory: nasal, throat swab, nasopharyngeal aspirate, tracheal wash fluid.
Enteric: feces
Genital: genital swab
Eye: conjunctival swab
Skin: vesicle swab or scrapping, biopsy of solid lesion.
CNS: cerebrospinal fluid
Generalized: nasal swab, feces, blood leukocytes, serum, urine.
Biopsy: relevant organ
Any disease: blood for serology
**Call labs to ensure what test tubes and other materials are necessary.

40
Q

Laboratory techniques to dx viral infection

A

Virus Detection

  • Virus Isolation: cell culture and CPE. Laboratory animals (mostly historical), egg culture
  • Virus visualization: electron microscope
  • Viral antigen detection: immunochemistry/immunofluorescence, ELISA.
  • Characteristic Gene Sequence: PCR, whole genome sequence, metagenomics.
41
Q

Virus detection by Cell Culture

A
  • Clinical specimen appropriately collected and filtered. Commonly conducted in microplates.
  • Inoculated to culture cells as a monolayer.
  • Selection of the cell type is critical to isolate the suspected virus.
  • Observe for 2-10 days.
  • Cells stain with Hemotoxylin and Eosin
  • Recognize characteristic cytopathic effect
42
Q

Virus Isolation: Embryonated egg

A
  • Influenza virus by allantoic and amniotic inoculation

- Historically used for pox virus isolation

43
Q

Visual detection

A
Electron microscope
A: Pox virus
B: Papilloma virus
C: Ebola virus
D: Reo 
E: Herpes
F: Rhabdo virus
G: Calici
H: Bunya
I: Orthomyxo
  1. Stain with 2% phosphotungstic and dry.
  2. Add copper grid
    20k magnification
44
Q

Viral antigen detection

A

-Immunochemistry, Immunofluorescence, ELISA

Eastern Equine Encephalitis Characteristic histopathology

  • sawhorse stance
  • Hemorrhage, neutrophil response recognized by H&E but pathologist can also use immunochemistry using antibodies to confirm.
  • Cerebrum samples postmortem small lymphocytes and neutrophils are effacing the vessel wall.

Immunochemistry/Immunofluorescence

  1. Tissue sample
    - Antibody and reporter enzyme
    - Antibody and fluorescent dye

ELISA:

  • Direct for antigen (virus) and indirect for antibody
  • Automated
  • SNAP test
    1. antibody at bottom of well. Sample to be tested has virus. Enzyme color added.
    2. indirect, Detecting antibody

a. k.a Immunomigration technology commercial application of ELISA
- Canine parvovirus and feline leukemia, and covid-19

45
Q

Diagnosis II

Characteristic gene sequencing

A
  • PCR: denature 90C, heat sensitive polymerase
  • Thermal bacterial idea for Tech polymerase
  • 1986 Mullins used Thermophilus aquatics DNA polymerase. Sold in 1991 300 million
  • TagMan: next generation PCR: real time PCR FRET
  • Molecular technology Changes in diagnostics virology today
  • PCR is not directly linked to viral genomic sequencing and has application in epidemiology Ex: South Africa VP1 FMD similar to UK isolates.
46
Q

Metagenomics: the study of genetic material recovered from an environmental sample
**PCR can only detect a known sequence

A
  • Hypothesis driven molecular testing such as PCR can involve numerous individual tests for specifically targeted organisms but may still miss a rare pathogen or use primers containing mismatches to the mitochondrial strain involve, which decreases the sensitivity of detection.
  • Metagenomic next-generation sequencing technologies and bioinformatics tools directly access the entire genetic content of a clinical sample
47
Q

Antibody detection

A
  • ELISA: virus antigen capturing body in well.
  • Virus neutralization

Principle: based on 4 fold rise in antibody level between acute and convalescent sera.

Problem: requires 2 samples to be collected. First serum sample is often collected too late. Difficult and cost prohibited
-These problems apply to serology for diagnosis, not for serological surveys to determine prevalence of infection in a population

48
Q

Virus neutralization test

A
  • N-point 1/128: good neutralizing antibodies
    1. Serially diluted serum (1:2, 1:4, etc)
    2. Add each dilution to separate wells of cultured cells
    3. Add equal amounts of virus to each well containing cultured cells and serum dilutions.
    4. Last dilution that can prevent plaque formation is antibody titer.
49
Q

What diagnostic test should be used?

A
  • What stage of the disease has been reached?
  • Do I know the sensitivity and specificity of the test I am using or requesting?
  • Do I suspect a notifiable disease?
  • If in doubt, consult the diagnostic laboratory

Criteria for selection of test

  • Speed
  • Sensitivity
  • Specificity
  • Simplicity
50
Q

Limitations of dx techniques

A
  • ELISA: cost effective in clinical practice
  • Virus isolation: expensive, but useful
  • PCR: cost effective, but needs sophisticated laboratory
  • Sequencing also needs sophisticated lab
  • Metagenomics is available only the most advanced
51
Q

Interpretation of lab findings

A

You decide if useful for your clinical case

  • consider site of specimen collection, pathogenicity, clinical presentation
  • Know specificity and sensitivity of test
  • Anticipate the consequences of reporting the test
  • Apply common sense

Case 1: Pseudocowpox, ring shape lesions, no systematic disease. Electron microscopy
Case 2. EEE 2yo philly. ELISA positive for virus
Case 3. Canine influenza. ELISA Ag positive

52
Q

Laboratory techniques used for Canine Influenza

A
  • Isolation of virus
  • PCR
  • Cellular pathology
  • Demonstration of antibody response
53
Q

COVID-19 test

A

-RNA virus. Recently CDC has developed a Multiplex RT-PCR for flu and COVID-19
Serves as a single test to diagnose infection caused by one of the three viruses.
Allows laboratories to process mores tests in a given period.
Information collected fast and available for disease surveillance/prevention
-Molecular test
-Viral isolation
-Serology testing
-Antibody test
-Antigen test: BinaxNow Ag card. Pink-purple line appears confirming that the reagents are working
**Make sure controls are present

54
Q

Veterinary virology: Vaccinations

A

Peter C. Doherty: only veterinarian to have received a nobel prize for his work on the major histamine complex.
MHC: group of genes that encode proteins found on the surface of cells that help the immune system recognize foreign substances. MHC proteins are found in all higher vertebrates. In human beings the complex is also called the human leukocyte antigen (HLA) system.

55
Q

Viral mechanisms to avoid immune response

A
  • Establishing a persistent infection: latency is protected in certain sites (nerve ganglia)
  • Growth in immune cells
  • Antigenic drift and antigenic shift
  • Suppression of class 1 MHC molecules to prevent CTL mediated killing of infected cells
  • Production of proteins that block signaling of cytokines and antiviral pathways for interferon
56
Q

Types of viral vaccines: History

A
  • Historical vaccines: Jennerian, cowpox vaccine
  • Workhorse vaccines: Live attenuated (MLV) were introduced before new molecular techniques several still in use, Inactivated vaccines (killed)
  • New generation vaccines: Recombinant and genetically engineered vaccines. Nucleic acid vaccines (DNA, mRNA)
  • *Most vaccines in the marker are attenuated or inactivated or live attenuated.

Inactivated
-EEE

Live Attenuated
-Canine distemper (MLV)

57
Q

Live attenuated vaccines

A
  • Generally better immunogens bc virus replicates in the host, thus producing longer lasting immunity similar to natural infection
  • *Gene deleted and marker vaccines

Pros

  • Single dose effective
  • Can be given by natural route stimulating local immunity
  • Produce long immunity
  • Inexpensive

Cons

  • Possible reversion to virulence
  • Possible spread to other animals
  • May not be attenuated for all species
58
Q

Inactivated vaccines

A

Pros

  • Stability
  • No danger of reversible virulence
  • No danger of spread
  • No problem with viral interference

Cons

  • Expensive
  • Multiple doses required
  • No local immunity interferon produced
  • Immunity often short lived
  • Any non-inactivated virus can cause disease

Adjuvants

  • agents used to enhanced the immunologic response
  • They cause slower release and degradation of antigens and stimulate phagocytosis
  • Aluminum hydroxide
  • Iscoms
  • Can be associated with sarcomas in cats
59
Q

Recombinant, genetically engineered vaccines

A

Gene deleted Vaccines

  • Receptor binding protein gene, virulence gene, Capsid protein gene.
  • Attenuation is now achieve through specific gene deletions

**Attenuated vaccines: based on one or more gene mutations produced by successive passage through cell cultures (>200 passages) until stable attenuated virus was recognized.

-Isolate virulence gene: the result is a viable virus immunogenic but not virulent
that may be used as a vaccine.

60
Q

Pseudo Rabies vx 1985, first recombinant live virus vaccine

Saul kit and colleagues

A

-1985: the first test of genetically altered virus vaccine in the US.

61
Q

Marker vaccine pioneered with pseudorabies

A
  • gp63 gene deleted
  • *For patenting reasons vaccine companies incorporate different deletions to create their marker vaccine.

Example:

  • Tk required for virulence, gp63 both deleted.
  • Attenuating the vaccine by removing thymidine kinase (TK) gene.

**No antibodies are made for gp63 when animal is vaccinated, however an active infection would produce gp63 antibody detected by ELISA

Disease eradication through the use of marker vaccines

-Europe is working towards eradication of IBR (infectious bovine rhinotracheitis.

In this case TK deleted and deletion of gene coding for the gE protein.
Cattle test negative ELISA, no infection
Those with gE antibody are detected and remove from the herd =DIVA principle (differentiation of infected from vaccinated animals).

62
Q

Recombinant Pox Vaccines

A

-Pox viruses have a large DNA genome
-Fowl pox virus does not replicate in mammals, but the inserted gene was transcribed and the mRNA translated yielding sufficient immunogenic protein to confer immunity
-Since only the genes coding for the major immunogenic proteins selected for expression in the vector, such vaccines can also be adapted to the DIVA principle
Examples: Canarypox vectored Equine Influenza virus.
Merial produced vectored vaccines based on canarypox, which is included on the label RecombiTek
The vaccine is not attenuated for black footed ferrets

ALVAC PureVax: canine distemper virus vaccine for ferrets, licensed and produced by Merial.

63
Q

PreveNile Vaccine for Horses Against West Nile virus

A
  • A recombinant vaccine based on a Yellow Fever backbone expressing an envelope protein of West Nile virus
  • June 4 2020 recall due to adverse events, anaphylaxis, respiratory distress, etc.
  • In the US all veterinary vaccines are licensed by USDA
64
Q

Non-replicating and replication vaccines

A

Non-replicating

  • Subunit
  • Virus-like proteins
  • Inactivated viruses
  • Nucleic acid
  • Non-replicating viral vectors

Replicating

  • Replicating vectors
  • Jennerian
  • Live-attenuated virus

**All vaccines should satisfy requirements of efficacy, safety, purity, and potency.

65
Q

Virus-like particles and Subunit vaccines

A
  • Recombinant technology used
  • Antigenic protein assembles to form capsid (VLP virus like particle)
  • An insect baculovirus is commonly used to produce the protein. The gene coding for the protein is inserted into the virus. Produced in vitro and purified before injection into target species.
  • Adjuvants are often used to potentiate the immune response

Example:

  • Porcine Circovirus Vaccine
  • Ingelvac CircoFLEX contains baculovirus, and adjuvant
66
Q

Nucleic Acid vax

A
  • Pfizer/Biotech and Moderna Covid-19 mRNA vaccine
  • mRNA technology at first did not produce robust immune antibody response. However, improvement in nanoparticles that protect the mRNA and allow it to be expressed occurred in 2020 during covid-19.
67
Q

Non-replicating viral vectors

A

-Oxford University/AztraZeneca, Johnson and Johnson, and Russian Sputnik Covid-19 vaccines use adenovirus vectors

68
Q

Live attenuated virus

A

Smallpox, rinderpest, and measles. For polio both live and inactivated vaccines have been used

69
Q

Nonavax Covid-19 vaccine

A
  • Growing spike proteins
  • Inserted spike gene in baculovirus. Infected moth cells, which produced spike proteins then joined together to form spikes like the virus.
  • Building nanoparticles: spike proteins harvested from moth cells and assembled together into nanoparticles. These mimicked the molecular structure of coronavirus, but they could replicate
  • Presenting the spike: the vaccines includes many nanoparticles which are injected in the muscle along with soapbark tree compound, which attracts immune cells to the site and causes robust reaction.
70
Q

DNA vaccines 2005

A
  • 2005 Atlanta CDC the world’s first licensed DNA vaccine. West Nile Virus vaccine
  • Plasmid DNA is processed by the cell and antigenic protein is expressed without need for a vector and induces antibody response.
  • None used in VetMed currently, but more likely mRNA seen first bc they are easier to manufacture
71
Q

mRNA vaccines

A

Moderna covid-19
-None in VetMed yet

How they work

  • mRNA in oily shell
  • the mRNA instructs the cells to make proteins.
  • Natural enzymes would chop it into pieces, but Moderna wrapped it in oily bubbles made of lipid nanoparticles.
  • Vaccine has to be refrigerated and stored at 20C up to six months.
  • Lab takes genome of cell and makes mRNA
72
Q

Some reasons why vaccines fail to protect

A
  • Improper use
  • Genetic differences between animals
  • Antigenic differences (vaccine strain not closely related to field strain)
  • Blocking by maternal antibodies (up to 12 weeks after birth)
  • Administration following infection
73
Q

Concept of Core Vaccination

A

AAFP core

  • Panleukopenia
  • Herpes
  • Calici
  • Rabies

Non core

  • FeLV
  • FIP
  • Chlamydia
  • Bordetella

Injection sites
Leukemia: left hind leg
Rabies: right hind leg

74
Q

Rabies wildlife vaccination

A

-Raboral V-RG approved by USDA for raccoons and coyotes

  • *Always think before using a vaccine
  • *Know the industry and consumer you are serving
75
Q

Veterinary Virology Epidemiology

A

An outbreak of Nervous Disease in Pigs

  • Salt poisoning
  • Nervous signs include ear twitching, aimless wondering, bumping into objects, dog-sitting, falling over sideways and apparent deafness and blindness. Affected pigs move around in a circle using one foot as a pivot and may convulse.

Epidemiology: study of the determinants, dynamics, and distribution of diseases in a population.

  • The risk of infection and/or disease is determined by the characteristics of the virus (e.g., antigenic variation), the host and population, behavioral, environmental, and ecological factors that affect viral transmission from one host to another.
  • Virus survive in nature only if they are able to pass from one host to another, whether the same or different species.
76
Q

Transmission routes for viruses

A

Horizontal

  • Direct contact
  • Indirect contact
  • Common vehicle: virus contaminated meat, water
  • Airborne
  • Arthropod borne: mechanical and biological

Vertical

  • Intra-uterine
  • Milk
  • Integration proviral DNA into germ line fertilized eggs

Collective transmission

  • Iatrogenic: caused by doctor
  • Nosocomial: in the veterinary hospital

Zoonotic
-Transmissible form animals to humans

77
Q

Mechanism of virus survival

A
  1. Acute self-limiting infection: high efficiency of transmission. Many individuals infected at the same time
    - Virus excretion of short duration
    - Immunity forces antigenic shift and drift, which allows virus to evade the immune response
    - Antigenic shift: sudden, new strain
    - Antigenic drift: slow, small mutations
    - Mixing vessel: pig, Influenza virus, antigenic shift.
  2. Persistent infection: prolonged period of excretion reduces the population necessary for transmission.
    -Promotes transmission for non-herding by venereal route
    -Antibody and virus can coexist
    Example: IBR (Infectious bovine rhinotracheitis)
  3. Resistance of the virus to the environment
    -Survival fomite transmission or in meat products
    -Virus not highly infectious.
    Example: Equine Warts, papilloma virus. African swine fever and virus in salami (harmful to vulnerable pigs not humans)
  4. Involvement of an intermediate host (arthropod-borne)
    Biological transmission when virus replicates in vector, blood meal, infected blood from animal, can cross species. Mechanical when they are passed via mouth parts.
    Example: West Nile virus. Carrier mosquito, Dead end host: humans, horses. Reservoir host: birds
  5. Congenital/vertical transmission: transplacental transmission. Perpetuation, recognition as self in fetus and newborn. Trans-mammary transmission also.
    Example: Caprine arthritis encephalopathy

*Virus perpetuation often involves wildlife
-Zoonotic viruses in many viral families.
Jump species, spillover and spill-back.

78
Q

SARS-Cov-2

A

Bats as virus reservoir

  • Human to human transmission
  • Short cycle transmission, low inocula necessary
  • We are still learning about this virus
79
Q

Seasonal variation in disease

A
  • Can be due to many causes
  • Arbovirus often seasonal disease
  • Housing management
  • Retreat to wildlife reservoirs and wait
  • Mosquito activity
80
Q

Vaccination goals

A
  • Eradication of disease
  • Reduce disease severity
  • Prevention of outbreaks/pandemics

Community immunity (herd immunity)

  • Slows down the spread
  • Protects those that can not be vaccinated
  • Smallpox, polio, measles, rinderpest.
81
Q

Molecular epidemiology

A

-Use of molecular biological methods for investigation of viral diseases
-‘Sequencing” means of identification of viral strains with specificity that surpasses serological methods
-GaMER: Genomics and Molecular Epidemiology Research
Example: VP1 (virus protein) of foot-and-mouth disease virus type O. UK strain and South Africa strain similarity concluded it came from S.A.

Big data and simple models track the spread of covid-19
-Understanding the dynamics, tracking human contacts via mobile-phone data

82
Q

Epidemic curve, Surveillance and Communication

A
  • Prevention: vaccination and surveillance
  • Early detection
  • Rapid response

ProMed Alerts, Google Alerts, Health Map, OIE (182 member countries), Food and Agricultural Organization, USDA,
Example:
West Nile Virus detected in a Zoo in NY
Canine Distemper March 2019

  • *Framework used
  • relate it to viral transmission and the “weak link”
  • From which we build up an assessment of risk and control policies
  • This leads to action in the veterinary practice but also government involvement at local, national, and international levels.

**The single biggest threat to man’s continued dominance in this planet is the virus.” Joshua Lederberg.